Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Contingent Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹368 Cr₹311 Cr₹159 Cr₹158 Cr₹141 Cr

What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?

The latest Contingent Liabilities ratio of AUROBINDO PHARMA is ₹368 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹368 Cr
Mar2024₹311 Cr
Mar2023₹159 Cr
Mar2022₹158 Cr
Mar2021₹141 Cr

How is Contingent Liabilities of AUROBINDO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹368 Cr
18.28
Mar2024 ₹311 Cr
96.39
Mar2023 ₹159 Cr
0.50
Mar2022 ₹158 Cr
12.01
Mar2021 ₹141 Cr -

Compare Contingent Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,947.6 Cr 6.2% 0.8% 9.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

6.2%

0.8%

9.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses